NEWS
Callisto Included in E2E 100 List
Jo Bunyan, Managing Director of Callisto Pharma Group has been included in the E2E Female 100 list in association with The Independent We are delighted to announce its inclusion in the 2023 E2E Female 100 list in association with The Independent and in...
Callisto adds more expertise to its GMDP team
We are pleased to announce that we have recruited again to our GMDP team as the group continues to grow. Amy has joined Callisto having previously worked as an RP, RPi and WQP for companies within the pharmaceutical wholesale industry. Amy is responsible for ensuring...
Callisto’s Charity of the Month – July 2022
We are extremely pleased to announce that the Charity for the month of July, chosen by our employee Elysia is Mid & South Essex Hospitals Charity. This charity is very personal to Elysia and we are pleased to help give something back so they can continue with...
Callisto expands Regulatory and PV teams
We are pleased to announce that we have recruited again to our Regulatory and PV teams as the group continues to grow. Isabelle Agar has joined Callisto after spending the previous 3 years within the pharmaceutical industry in both primary and secondary care account...
Callisto Invests in Safety Database
In line with our ongoing expansion and evolving client requirements, Callisto Pharma Group are delighted to announce that they have recently invested in a new Pharmacovigilance database. This investment is as a direct result of our commitment to provide effective...
Callisto Charity Of The Month – June 2022
We are extremely pleased to announce that the Charity for the month of June, chosen by our employee Raheesa is Operation Smile. Millions of children living with untreated cleft conditions have difficulties eating, breathing, speaking and being accepted by many of...
like to know more
Say Hello!
If you would like to find out more about any of our services please fill out the form below. We would love to here from you.
